Peter Bradley, Gaicd Email and Phone Number
Adelaide, SA, AU
Peter Bradley, Gaicd's Location
Adelaide, South Australia, Australia, Australia
Peter Bradley, Gaicd's Contact Details
Peter Bradley, Gaicd work email
- Valid
- Valid
- Valid
Peter Bradley, Gaicd personal email
n/a
Peter Bradley, Gaicd phone numbers
About Peter Bradley, Gaicd
Over 30 years experience in all aspects of medical science and business. Highly skilled, scientifically trained leader with a wide knowledge of the health, pharmaceutical and laboratory based businesses. Extensive knowledge and experience in commercialisation of science with hands on experience in developing and marketing biotechnology based products.Specialties: • Path to market planning and technology assessment• Strategic Planning and Marketing Positioning• Market Opportunities and Business Development• Partnering and Relationship Management• Competitor Analysis - Local & Global• Negotiation and Project Management • Regulatory advice and project planning
Peter Bradley, Gaicd's Current Company Details
Peter Bradley, Gaicd Work Experience Details
-
Chief Commercial Officer (Cco)Protego MedicalAdelaide, Sa, Au
-
Non Executive DirectorBiosensis Pty Ltd Dec 2023 - PresentThebarton, South Australia, AuBiosensis is dedicated to the support of researchers in academia and industry worldwide. The management team has a combined total of over 100 years of experience in basic and applied life science research and over 70 years in the commercialization of life science antibodies, reagents, and kits for the life science research and diagnostic markets. We therefore intimately understand the need for researchers to have quality reagents that work. With a combined total of 400+ peer-reviewed research publications and superb technical support and experience, Biosensis is able to offer a level of customer support and scientific expertise unmatched in the industry for Neuroscience and its related research fields. -
Chief Commercial Officer (Cco)Protego Medical Jun 2023 - PresentProtego Medical is where innovation and healthcare meet to improve patient lives and enhance healthcare efficiencies.Our mission is to scout, develop, and bring to market breakthrough innovations that elevate patient and hospital outcomes. We take pride in pioneering the commercialization of the world’s first Sternum Protection Device (SPD®), a groundbreaking tool designed to revolutionize cardiac surgery procedures.
-
Managing DirectorQatalyst Bioconsulting Jan 2003 - PresentQatalyst BioConsulting is a consultancy for bio-marketing and commercialisation. It provides Medical Technology, Biotechnology companies and healthcare organisations with critical market intelligence, information and commercialisation assistance. It has worked with a range of companies from start-ups through to established global players.
-
General ManagerClever Culture Systems Jul 2013 - Nov 2022Pfäffikon , ChClever Culture Systems is the joint venture between LBT Innovations and Andreas Hettich GmbH. Established in 2013, this company brings together the synergistic capabilities of the two companies. LBT Innovations’ clinical technology expertise and Hettich’s hardware development skill-set to drive the commercial development and distribution of LBT’s Automated Plate Assessment System (APAS). THE CLEVER WAY TO AUTOMATE PLATE READING The market-leading, innovative technology streamlines busy microbiology laboratory workflows, offering a modular approach. The APAS Independence is a stand-alone automated culture plate reading instrument that accurately and efficiently screens and sorts significant and insignificant growth plates at a rate of 200 plates per hour. The innovative, FDA cleared culture plate classification system identifies negative plates, allowing microbiologists to focus on the positive and significant growth plates that require their time and expertise, accelerating patient diagnosis. -
Vice President Global Business DevelopmentLbt Innovations Ltd Oct 2012 - Nov 2022Adelaide, South Australia, AuLBT Innovations Ltd is an Australian developer of clinical and diagnostic technology. Based in Adelaide, South Australia, the Company was formed in 2004 and listed on the Australian Securities Exchange in July 2006 (ASX: LBT). The company’s ambition is to become a leader in innovation in the international pathology laboratory market with multiple products to take to that market. LBT Innovations receives milestone and royalty payments for its first product, marketed globally as PREVI™ Isola, which automates the inoculation and streaking of culture plates in clinical microbiology laboratories.The company is actively pursuing growth of its technology pipeline and is currently evaluating commercialisation options for its second product, APAS, which automates the screening and interpretation of agar plates following incubation. -
Chairman - Auckland LifesciencesAuckland Tourism, Events & Economic Development (Ateed) Oct 2008 - Oct 2012Auckland Life Sciences is an industry driven body that works in collaboration with its partners, and supported by ATEED to finalise a long term strategy and action plan for the Life Sciences sector in Auckland. It leads the development of strategy advice for the sector upon which ATEED will make recommendations to the Auckland Council and other government bodies as a whole. The strategy continues to take its lead from industry, remain in touch with national objectives, and provide a framework for leveraging support and opportunities for Life Science based industry in Auckland.
-
Chief Business Development OfficerInnate Immunotherapeutics Feb 2008 - Oct 2012Innate Immunotherapeutics Limited is a public unlisted biotech company based in Auckland, NZ. The Company has designed and manufactured a unique immunomodulator microparticle technology. This technology can be used to induce the human immune system to fight certain cancers and infections, or turn off certain immune mechanisms which lead to autoimmune diseases such as Multiple Sclerosis. The same technology can be used in the design of better vaccines to potentially treat or prevent diseases such as influenza, cancer, malaria, or tuberculosis. The microparticle at the core of this technology provides a unique delivery system for a suite of both known and novel immune system triggers or modulators. By attaching selected modulators to the microparticle, these triggers can be delivered reliably to specific cells of the immune system. Target diseases or applications for drugs developed using this approach include:•Auto-immune diseases such as Multiple Sclerosis; •Certain cancers that are known to be immune-sensitive, such as prostate, colon, & renal cancer; •Infectious diseases such as influenza and hepatitis B and C; and •Preventive vaccines for malaria and tuberculosis, and therapeutics vaccines for cancers. The first drug candidate developed using this technology, MIS416, combines two well described immunostimulatory ligands or triggers -NOD2 & TLR9. MIS416, has demonstrated safety and efficacy in a number of different disease or injury models. Multiple Sclerosis has been selected as the disease target for a human Phase 2 programme. The Phase 2A due to commence in New Zealand in early 2010.
-
Chief Executive Officer (Interim)Nzbio Feb 2011 - Apr 2011NZBIO is an incorporated society representing the New Zealand biotechnology sector. We have a broad range of members engaged in a number of different activities, and strong connections into regional and national networks.NZBIO’s vision is for the growth of a prosperous New Zealand biotechnology sector. New Zealand’s biotechnology sector is increasingly seen as exciting, innovative and a distinctive New Zealand strength. Biotechnology underpins New Zealand’s fast growing economy, and is an essential tool for maintaining and improving the environment. NZBIO’s mission is to create the environment for a prosperous New Zealand biotechnology sector. -
Ceo And Managing DirectorKode Biotech Dec 2005 - Dec 2007Auckland, Auk, NzCEO of KODE Biotech Limited. KODE Biotech Limited is based on its novel KODE technology platform which allows the harmless coating of bioactive molecules onto the outside of cell surfaces. Specific products in development include embryo adhesion molecules, diagnostic infectious disease screening assays and therapeutic immunological applications. In addition KODE Biotech Limited has a substantial IP portfolio which can be accessed by licensing or partnering. -
CeoAustralian Orthopaedic Innovations Aug 2004 - Dec 2005Australian Orthopaedic Innovations Pty Ltd (AOI) is a South Australian company developing and commercialising orthopaedic research. Whilst I was there we had two innovative products in development for the international market: an Adaptive Orthopaedic Handpiece for optimal long-term fixation of prosthetic devices; and a Bone Chemical Supplementation for prevention of infection in bone grafts.
-
Project ManagerBio Innovation Sa 2003 - Dec 2005Bio Innovation SA was established in June 2001 to accelerate development of South Australia’s bioscience sector. The Bio Innovation SA team works with the bioscience community using a synergistic approach to industry development focusing on a range of commercial activities.
-
Divisional ManagerMedvet Science May 1999 - Jan 2003MedVet Science had four divisions at the time and I was manager of the largest - the Diagnostics until mid 2000 when I became Sales and Marketing Manager - managing not only product development but distributor management and export to over 30 countries.
-
Product Development And Regulatory Affairs ManagerCsl Limited 1986 - 1999Melbourne, Victoria, AuCSL is Australia’s largest biopharmaceutical developer and manufacturer. The Biosciences Division is focussed on the development and supply of clinical laboratories particularly for blood transfusion and infectious disease.I was responsible for;• Divisional Technology Strategy• The assessment of new product development and business opportunities, intellectual property and the licensing of technology• Managing internal and external R&D programs• Provide scientific, regulatory and technical support to marketing, sales and manufacturing.
Peter Bradley, Gaicd Skills
Biotechnology
Lifesciences
Commercialization
Biopharmaceuticals
Strategy
Medical Devices
Immunology
Start Ups
R&d
Technology Transfer
Business Development
Life Sciences
Regulatory Affairs
Product Development
Vaccines
Pharmaceutical Industry
Infectious Diseases
Entrepreneurship
Market Development
Competitive Analysis
Clinical Development
Global Business Development
Laboratory Medicine
Drug Development
Product Launch
Collaboration
Hardware Diagnostics
Cell
Oncology
Laboratory
Licensing
Venture Capital
Pharmaceutics
Clinical Trials
Corporate Development
Fda
Culinary Skills
Technology Evaluation
Clinical Research
Blood Bank
Innovation Management
Assay Development
Gmp
Strategic Alliances
Patents
Diagnostics
Cro
Global Marketing
Cancer
Medical Diagnostics
Peter Bradley, Gaicd Education Details
-
Australian Institute Of Company DirectorsGraduate -
Melbourne Business SchoolTechnology Management
-
Australian Institiute Of Medical ScientistsBlood Transfusion
-
University Of South AustraliaMedical Science
-
Salesian College
-
Saint Mary'S Primary School
Frequently Asked Questions about Peter Bradley, Gaicd
What company does Peter Bradley, Gaicd work for?
Peter Bradley, Gaicd works for Protego Medical
What is Peter Bradley, Gaicd's role at the current company?
Peter Bradley, Gaicd's current role is Chief Commercial Officer (CCO).
What is Peter Bradley, Gaicd's email address?
Peter Bradley, Gaicd's email address is pe****@****ons.com
What is Peter Bradley, Gaicd's direct phone number?
Peter Bradley, Gaicd's direct phone number is +614281*****
What schools did Peter Bradley, Gaicd attend?
Peter Bradley, Gaicd attended Australian Institute Of Company Directors, Melbourne Business School, Australian Institiute Of Medical Scientists, University Of South Australia, Salesian College, Saint Mary's Primary School.
What skills is Peter Bradley, Gaicd known for?
Peter Bradley, Gaicd has skills like Biotechnology, Lifesciences, Commercialization, Biopharmaceuticals, Strategy, Medical Devices, Immunology, Start Ups, R&d, Technology Transfer, Business Development, Life Sciences.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial